FdaApplication
ANDA 217535
Identifiers
- fda_app_no: ANDA217535
Properties
| Property | Value |
|---|---|
| applicant_name | NEXUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2023-08-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SODIUM CHLORIDE 0.9% | SODIUM CHLORIDE | 180MG/20ML (9MG/ML) | SOLUTION;INJECTION |
| SODIUM CHLORIDE 0.9% | SODIUM CHLORIDE | 90MG/10ML (9MG/ML) | SOLUTION;INJECTION |
2 products